These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3075225)

  • 1. [Newer pathophysiologic considerations and treatment of neonatal respiratory distress syndrome (RDS)].
    Fujiwara T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1033-43. PubMed ID: 3075225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
    Jobe A
    Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
    Reynolds MS; Wallander KA
    Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?
    Sinha S; Moya F; Donn SM
    Curr Opin Pediatr; 2007 Apr; 19(2):150-4. PubMed ID: 17496757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
    Wirbelauer J; Speer CP
    J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
    Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
    J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant and RDS in premature infants.
    Lynch RG
    FASEB J; 2004 Oct; 18(13):1624. PubMed ID: 15466362
    [No Abstract]   [Full Text] [Related]  

  • 10. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein leaks and surfactant dysfunction in the pathogenesis of respiratory distress syndrome.
    Jobe A
    Eur Respir J Suppl; 1989 Mar; 3():27s-32s. PubMed ID: 2742683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lung disease of the very low birth weight infant--is it preventable?
    Ogawa Y
    Turk J Pediatr; 1998; 40(1):35-44. PubMed ID: 9673527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited disorders of neonatal lung diseases.
    Yurdakök M
    Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The exogenous surfactant and its effect on the respiratory distress syndrome (RDS)].
    Brabec R; Zoban P; Tomásová H
    Cesk Fysiol; 1996 Sep; 45(3):139-45. PubMed ID: 8974827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
    Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant replacement: immunological considerations.
    Strayer DS; Merritt TA; Hallman M
    Eur Respir J Suppl; 1989 Mar; 3():91s-96s. PubMed ID: 2742687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome.
    Bae YM; Bae CW; Oh MH; Lee SH; Woo KM; Jung KB
    J Perinat Med; 2009; 37(5):561-4. PubMed ID: 19492923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surfactant to premature neonates].
    Jacobsen T; Verder H
    Ugeskr Laeger; 1991 Jul; 153(31):2166-9. PubMed ID: 1866827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.